HiroyuHatanoMD

Internal Medicine • Palo Alto, CA

Infectious Disease

Assistant Professor, Medicine, University of California, San Francisco, School of Medicine

Join to view full profile

Are you Dr. Hatano?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3200 Middlefield Rd
Ste C
Palo Alto, CA 94306
Phone+1 650-850-4111

Fax+1 650-666-8219

Summary

Dr. Hiroyu Hatano, MD is a board certified internist in Palo Alto, California. She is currently licensed to practice medicine in California and Massachusetts. She is affiliated with Stanford Health Care and is an Assistant Professor at University of California.

Education & Training

University of California (San Francisco)Fellowship, Infectious Disease, 2004 - 2007
Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
Stanford University School of MedicineClass of 2001

Certifications & Licensure

CA State Medical License 2004 - 2026
MA State Medical License 2003 - 2006
American Board of Internal Medicine Internal Medicine

Clinical Trials

Raltegravir Intensification in HIV-infected Patients Start of enrollment: 2008 Feb 01
Completed
Phase 4
HIV Persistence and Viral Reservoirs Start of enrollment: 2009 Dec 01
Completed
Phase 4
The Use of Leukapheresis to Support HIV Pathogenesis Studies Start of enrollment: 2010 Oct 26
Recruiting
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies Start of enrollment: 2011 Apr 01
Recruiting
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study Start of enrollment: 2012 Feb 01
Completed
Phase 4
Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial Start of enrollment: 2014 Oct 16
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease.
Alton Barbehenn, Lei Shi, Junzhe Shao, Rebecca Hoh, Heather M Hartig
Nature Communications. 2024-11-18
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease.
Alton Barbehenn, Lei Shi, Junzhe Shao, Rebecca Hoh, Heather M Hartig
Medrxiv. 2024-08-22
12 citations
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response.
Guoxin Wu, Paul Zuck, Shih Lin Goh, Jeffrey M. Milush, Poonam Vohra
The Journal of Infectious Diseases. 2021-11-16

Grant Support

Virologic And Host Factors Contributing To HIV Control In Elite ControllersNational Institute Of Allergy And Infectious Diseases2007–2011